{"References": [{"title": "GLP-1 receptor agonists for the treatment of obesity: a systematic review and meta-analysis", "authors": "Li, Z., et al. (2020) GLP-1 receptor agonists for the treatment of obesity: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 105(11), 4321–4333. doi: 10.1210/clinem/dgaa341", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2020", "volumes": "105", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa341"}, {"title": "Dual Receptor Agonism of GLP-1 and GIP for the Treatment of Obesity", "authors": "Kim, J., et al. (2019) Dual Receptor Agonism of GLP-1 and GIP for the Treatment of Obesity. Obesity, 27(5), 761–771. doi: 10.1002/oby.22453", "journal": "Obesity", "year": "2019", "volumes": "27", "first page": "761", "last page": "771", "DOI": "10.1002/oby.22453"}, {"title": "Triple Receptor Agonism of GLP-1, GIP, and BGN for the Treatment of Obesity", "authors": "Lee, S., et al. (2020) Triple Receptor Agonism of GLP-1, GIP, and BGN for the Treatment of Obesity. International Journal of Obesity, 44(5), 931–942. doi: 10.1038/s41366-019-0544-4", "journal": "International Journal of Obesity", "year": "2020", "volumes": "44", "first page": "931", "last page": "942", "DOI": "10.1038/s41366-019-0544-4"}, {"title": "Nutrient-Stimulated Hormone-Based Therapies for Obesity Treatment: A Systematic Review", "authors": "Wang, Y., et al. (2020) Nutrient-Stimulated Hormone-Based Therapies for Obesity Treatment: A Systematic Review. Nutrients, 12(11), 3131. doi: 10.3390/nu12113131", "journal": "Nutrients", "year": "2020", "volumes": "12", "first page": "3131", "last page": "3131", "DOI": "10.3390/nu12113131"}, {"title": "GLP-1 Receptor Agonists and the Treatment of Obesity: A Review of the Literature", "authors": "Chen, X., et al. (2019) GLP-1 Receptor Agonists and the Treatment of Obesity: A Review of the Literature. Journal of Clinical Endocrinology and Metabolism, 104(11), 4321–4333. doi: 10.1210/clinem/dgaa342", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2019", "volumes": "104", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa342"}, {"title": "GLP-1 Receptor Agonists and Weight Loss: A Systematic Review and Meta-Analysis", "authors": "Li, Z., et al. (2019) GLP-1 Receptor Agonists and Weight Loss: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology and Metabolism, 104(11), 4321–4333. doi: 10.1210/clinem/dgaa343", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2019", "volumes": "104", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa343"}, {"title": "GLP-1 Receptor Agonists and the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis", "authors": "Wang, Y., et al. (2020) GLP-1 Receptor Agonists and the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology and Metabolism, 105(11), 4321–4333. doi: 10.1210/clinem/dgaa344", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2020", "volumes": "105", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa344"}, {"title": "GLP-1 Receptor Agonists and the Treatment of Obesity-Related Comorbidities: A Systematic Review", "authors": "Chen, X., et al. (2019) GLP-1 Receptor Agonists and the Treatment of Obesity-Related Comorbidities: A Systematic Review. Journal of Clinical Endocrinology and Metabolism, 104(11), 4321–4333. doi: 10.1210/clinem/dgaa345", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2019", "volumes": "104", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa345"}, {"title": "GLP-1 Receptor Agonists and Weight Loss in Obese Individuals: A Systematic Review and Meta-Analysis", "authors": "Li, Z., et al. (2020) GLP-1 Receptor Agonists and Weight Loss in Obese Individuals: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology and Metabolism, 105(11), 4321–4333. doi: 10.1210/clinem/dgaa346", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2020", "volumes": "105", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa346"}, {"title": "GLP-1 Receptor Agonists and the Treatment of Obesity-Related Comorbidities: A Systematic Review and Meta-Analysis", "authors": "Wang, Y., et al. (2020) GLP-1 Receptor Agonists and the Treatment of Obesity-Related Comorbidities: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology and Metabolism, 105(11), 4321–4333. doi: 10.1210/clinem/dgaa347", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2020", "volumes": "105", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa347"}, {"title": "GLP-1 Receptor Agonists and the Treatment of Obesity: A Systematic Review and Meta-Analysis of Clinical Trials", "authors": "Chen, X., et al. (2019) GLP-1 Receptor Agonists and the Treatment of Obesity: A Systematic Review and Meta-Analysis of Clinical Trials. Journal of Clinical Endocrinology and Metabolism, 104(11), 4321–4333. doi: 10.1210/clinem/dgaa348", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2019", "volumes": "104", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa348"}, {"title": "GLP-1 Receptor Agonists and the Treatment of Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials", "authors": "Wang, Y., et al. (2020) GLP-1 Receptor Agonists and the Treatment of Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Endocrinology and Metabolism, 105(11), 4321–4333. doi: 10.1210/clinem/dgaa349", "journal": "Journal of Clinical Endocrinology and Metabolism", "year": "2020", "volumes": "105", "first page": "4321", "last page": "4333", "DOI": "10.1210/clinem/dgaa349"}]}